Join imec’s CTO Health Peter Peumans for an open and interactive roundtable discussions focusing on how deeptech can improve precision, turnaround time and yield in cell and gene therapy.
Topics to be discussed:
- What are the new, upcoming innovation challenges- both in clinical practice and in discovery – with regards to manufacturing technology and analytical instrumentation and within what time frame are these needed?
- How to optimize therapy development for solid vs. liquid tumors? How to work with challenges in patient profiling, precise transfection and multimarker cell selection. How to deal with manufacturing challenges coming from the above?
- Where can deeptech (unique hardware, software and AI co-development) have an impact on cell and gene therapy manufacturing (modular, scalable, miniaturized, online)?
- What collaboration forms are needed to enable this?